Your browser doesn't support javascript.
loading
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck.
Margalit, Danielle N; Haddad, Robert I; Tishler, Roy B; Chau, Nicole G; Schoenfeld, Jonathan D; Bakst, Richard L; Misiukiewicz, Krzysztof J; Gupta, Vishal; Posner, Marshall; Hanna, Glenn J; Mahmood, Umair; Rawal, Bhupendra; Catalano, Paul J; Rath, Lynda; Bacay, Alyssa; McHugh, Patricia; Rabinowits, Guilherme.
Afiliação
  • Margalit DN; Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts. Electronic address: danielle_margalit@dfci.harvard.edu.
  • Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Tishler RB; Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Chau NG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Schoenfeld JD; Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Bakst RL; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York.
  • Misiukiewicz KJ; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York.
  • Gupta V; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York.
  • Posner M; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York.
  • Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Mahmood U; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Rawal B; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Catalano PJ; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Rath L; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York.
  • Bacay A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • McHugh P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Rabinowits G; Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
Int J Radiat Oncol Biol Phys ; 105(1): 132-139, 2019 09 01.
Article em En | MEDLINE | ID: mdl-31082494
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article